Deutsche Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$584M Buy
10,143,181
+1,106,696
+12% +$63.5M 0.17% 120
2026
Q1
$548M Buy
9,036,485
+240,752
+3% +$14M 0.18% 124
2025
Q4
$474M Buy
8,795,733
+226,088
+3% +$10.9M 0.15% 132
2025
Q3
$386M Sell
8,569,645
-778,915
-8% -$36.4M 0.13% 159
2025
Q2
$433M Sell
9,348,560
-231,896
-2% -$11.4M 0.16% 133
2025
Q1
$584M Buy
9,580,456
+13,995
+0.1% +$816K 0.23% 90
2024
Q4
$541M Buy
9,566,461
+904,613
+10% +$50.5M 0.21% 96
2024
Q3
$448M Buy
8,661,848
+750,115
+9% +$35.2M 0.18% 109
2024
Q2
$329M Sell
7,911,733
-270,435
-3% -$12.1M 0.15% 139
2024
Q1
$444M Sell
8,182,168
-5,377,936
-40% -$274M 0.21% 102
2023
Q4
$696M Sell
13,560,104
-2,315,436
-15% -$122M 0.35% 56
2023
Q3
$921M Sell
15,875,540
-2,028,553
-11% -$124M 0.6% 26
2023
Q2
$1.14B Sell
17,904,093
-1,477,009
-8% -$99M 0.61% 24
2023
Q1
$1.34B Buy
19,381,102
+1,263,969
+7% +$89.1M 0.75% 19
2022
Q4
$1.3B Buy
18,117,133
+22,713
+0.1% +$1.71M 0.75% 19
2022
Q3
$1.29B Buy
18,094,420
+36,610
+0.2% +$2.66M 0.78% 20
2022
Q2
$1.39B Sell
18,057,810
-816,863
-4% -$62.2M 0.78% 19
2022
Q1
$1.38B Buy
18,874,673
+3,501,688
+23% +$235M 0.64% 25
2021
Q4
$959M Buy
15,372,985
+2,232,347
+17% +$131M 0.43% 44
2021
Q3
$778M Buy
13,140,638
+1,253,604
+11% +$82.6M 0.37% 52
2021
Q2
$794M Buy
11,887,034
+936,526
+9% +$61.1M 0.39% 45
2021
Q1
$691M Buy
10,950,508
+910,771
+9% +$56.7M 0.37% 52
2020
Q4
$623M Buy
10,039,737
+56,279
+0.6% +$3.46M 0.38% 43
2020
Q3
$602M Buy
9,983,458
+1,596,169
+19% +$96.1M 0.41% 44
2020
Q2
$493M Buy
8,387,289
+1,248,875
+17% +$74.7M 0.37% 51
2020
Q1
$398M Sell
7,138,414
-711,987
-9% -$43.5M 0.36% 53
2019
Q4
$504M Buy
7,850,401
+834,849
+12% +$47.8M 0.33% 56
2019
Q3
$356M Sell
7,015,552
-105,988
-1% -$4.98M 0.25% 82
2019
Q2
$323M Sell
7,121,540
-1,122,426
-14% -$52.3M 0.19% 104
2019
Q1
$393M Buy
8,243,966
+1,342,069
+19% +$66.9M 0.23% 82
2018
Q4
$359M Buy
6,901,897
+565,445
+9% +$30.4M 0.25% 84
2018
Q3
$393M Buy
6,336,452
+504,002
+9% +$29.9M 0.2% 103
2018
Q2
$323M Sell
5,832,450
-899,640
-13% -$48.6M 0.16% 128
2018
Q1
$426M Buy
6,732,090
+501,349
+8% +$32.3M 0.2% 98
2017
Q4
$382M Buy
6,230,741
+1,699,295
+38% +$106M 0.24% 88
2017
Q3
$289M Sell
4,531,446
-2,767,744
-38% -$162M 0.2% 101
2017
Q2
$407M Buy
7,299,190
+937,952
+15% +$51M 0.29% 72
2017
Q1
$346M Buy
6,361,238
+1,105,271
+21% +$60.6M 0.26% 86
2016
Q4
$307M Sell
5,255,967
-2,074,278
-28% -$113M 0.25% 86
2016
Q3
$395M Buy
7,330,245
+1,558,495
+27% +$100M 0.28% 79
2016
Q2
$425M Buy
5,771,750
+1,112,413
+24% +$78.6M 0.3% 70
2016
Q1
$298M Sell
4,659,337
-2,487,115
-35% -$157M 0.22% 93
2015
Q4
$492M Buy
7,146,452
+2,393,089
+50% +$158M 0.34% 57
2015
Q3
$281M Buy
4,753,363
+337,651
+8% +$21.4M 0.22% 96
2015
Q2
$294M Sell
4,415,712
-1,009,635
-19% -$66.5M 0.19% 122
2015
Q1
$350M Buy
5,425,347
+759,275
+16% +$47.5M 0.22% 103
2014
Q4
$275M Sell
4,666,072
-28,024
-0.6% -$1.58M 0.17% 136
2014
Q3
$240M Sell
4,694,096
-237,823
-5% -$11.9M 0.15% 163
2014
Q2
$239M Buy
4,931,919
+425,576
+9% +$21M 0.16% 142
2014
Q1
$234M Sell
4,506,343
-157,242
-3% -$8.37M 0.17% 142
2013
Q4
$248M Sell
4,663,585
-795,297
-15% -$40.5M 0.18% 122
2013
Q3
$253M Sell
5,458,882
-418,428
-7% -$18.4M 0.19% 119
2013
Q2
$263M Buy
+5,877,310
New +$255M 0.22% 95

Other funds holding BMY

Deutsche Bank's BMY Position: Q2 2026 in Review

Deutsche Bank increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $63.5M and bringing the position to 10,143,181 shares worth $584M. The position accounts for 0.17% of the portfolio, ranked #120.

Deutsche Bank first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.39B in Q2 2022. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Deutsche Bank held 10,143,181 shares of Bristol-Myers Squibb worth $584M as of Q2 2026.
  • Deutsche Bank bought 1,106,696 Bristol-Myers Squibb shares in Q2 2026, an estimated $63.5M.
  • Bristol-Myers Squibb made up 0.17% of Deutsche Bank's portfolio in Q2 2026, its #120 holding.
  • Deutsche Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Bristol-Myers Squibb position peaked at $1.39B in Q2 2022.
  • 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.